Experience

Davis Polk advised the initial purchasers on a Rule 144A and Regulation S offering of $300 million aggregate principal amount of 8.875% senior notes due 2025 of Credivalores–Crediservicios…

Davis Polk advised the joint book-running managers and representatives of the initial purchasers on a Rule 144A offering by Integra LifeSciences Holdings Corporation of $575 million…

Davis Polk advised the joint bookrunners in connection with the initial public offering by Mitre Realty Empreendimentos e Participações S.A. and the selling shareholder of 54,545,454 common…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of CAD1 billion aggregate principal amount of floating-rate senior notes due 2023. The notes, which…

Davis Polk advised Reynolds Consumer Products Inc. on its $1.4 billion initial public offering of 54,245,500 shares of common stock, which includes the full exercise of the underwriters’…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $281.75 million initial public offering by 1Life Healthcare, Inc…

Davis Polk advised Grupo Aval Acciones y Valores S.A. in connection with its global offering of $1 billion aggregate principal amount of 4.375% senior notes due 2030. The notes were issued…

Davis Polk acted as special product counsel to the representative of the initial purchasers in connection with a Rule 144A offering by Live Nation Entertainment, Inc. of an aggregate…

Davis Polk is advising Kissner Group Holdings LP and its equityholders, including affiliated investment funds managed by Metalmark Capital LLC and Silvertree-KMC II LP, a venture between…

Davis Polk advised the underwriters in connection with Alector, Inc.’s $240 million public offering of 9,602,500 shares of common stock, which includes the 1,252,500 shares offered pursuant…